Rice Hall James & Associates’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
VCM
GKFF
GS
Rice Hall James & Associates's ASPN Position: Q1 2026 in Review
Rice Hall James & Associates increased its Aspen Aerogels (ASPN) stake by 9.2% in Q1 2026, buying an estimated $442K and bringing the position to 1,552,628 shares worth $5.31M. The position accounts for 0.3% of the portfolio, ranked #80.
Rice Hall James & Associates first reported a position in ASPN in Q2 2023 and has held it in 12 quarters since. The position peaked at $14.8M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- Rice Hall James & Associates held 1,552,628 shares of Aspen Aerogels worth $5.31M as of Q1 2026.
- Rice Hall James & Associates bought 131,023 Aspen Aerogels shares in Q1 2026, an estimated $442K.
- Aspen Aerogels made up 0.3% of Rice Hall James & Associates's portfolio in Q1 2026, its #80 holding.
- Rice Hall James & Associates first reported a position in Aspen Aerogels in Q2 2023 and has held it in 12 quarters since.
- Rice Hall James & Associates's Aspen Aerogels position peaked at $14.8M in Q3 2024.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.